Antiviral activity of molnupiravir against COVID-19: a schematic review of evidences
Review
[키워드] active form
animal model
animal models
antiviral activity
Antiviral effect
antiviral efficacy
antiviral medicine
Cell
clinical
clinical trials
conducted
country
COVID-19
death
Efficacy and safety
EIDD-1931
EIDD-2801
evaluate
Evidence
highly pathogenic
Hospitalization
in vitro
in vivo
individuals with COVID-19
infected with COVID-19
lab
mechanism of action
medication
moderate
molnupiravir
multiple coronaviruses
outcome
pathogen
reduced
Replication
Research
responsible
risk
SARS-CoV-2
Severe case
Spread
Treatment
Viral RNA
[DOI] 10.1186/s42269-022-00753-9 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s42269-022-00753-9 PMC 바로가기 [Article Type] Review